NCT05848310 Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
| NCT ID | NCT05848310 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Biliary Atresia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-10-15 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-10-15 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
Eligibility Criteria
Inclusion Criteria: * Samples diagnosed as biliary atresia in Children's Hospital of Fudan University * Samples with one-year follow-up records after surgery * Samples with a record of serum total bilirubin levels three months after surgery * Samples with preoperative serum left（volume \> 500ul) Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05848310 clinical trial?
This trial is open to participants of all sexes, studying Biliary Atresia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05848310 currently recruiting?
Yes, NCT05848310 is actively recruiting participants. Contact the research team at szheng@shmu.edu.cn for enrollment information.
Where is the NCT05848310 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT05848310 clinical trial?
NCT05848310 is sponsored by Children's Hospital of Fudan University. The trial plans to enroll 200 participants.